Skip to content

The Nocturnal Enuresis Alarm Therapy (NEAT) Study

A randomised controlled trial comparing the proportion of patients with nocturnal enuresis cured at 4 months by the code game alarm or with the standard enuresis alarm

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12609000070235
Acronym
NEAT Study
Enrollment
320
Registered
2009-01-28
Start date
2009-05-07
Completion date
2010-12-29
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Bedwetting affects 10% school aged children and 2% adults. It impacts on sleep, concentration, learning and self esteem. First line treatment is with a bedwetting alarm. The Children’s Hospital at Westmead has designed a bedwetting alarm which is more effective, including in those who had previously failed alarm therapy. This alarm incorporates the latest technology with a new concept in treating bedwetting. The predicted success rate is 80-95% (compared with 65-75% for standard alarms).We aim to further refine the proof of concept alarm and compare it to standard alarms.

Interventions

A novel code game enuresis alarm which needs a code word for sensing wettness. The sensor is secured in a pad and can be worn inside the child's underpants. This alarm will emit an audio signal to wake the child. The participant will be using this alarm until cure or for a maximum of 4 months.

Sponsors

National Health and Medical Research Council
Lead SponsorGovernment body

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used) (Investigator)

Eligibility

Sex/Gender
All
Age
6 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

Children >6 years with nocturnal enuresis for at least 3 nights per week for which enuresis alarm therapy is indicated

Exclusion criteria

Children with organic cause for nocturnal enuresis, defects of central nervous system or significant underlying urological abnormalities or those where alarm therapy is contraindicated.

Outcome results

None listed

Source: ANZCTR · Data processed: Mar 3, 2026